These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 9680498

  • 21. [Motility of the large intestine: from irritable colon to obstipation].
    Meyer-Wyss B.
    Ther Umsch; 1991 Jul; 48(7):488-93. PubMed ID: 1926009
    [Abstract] [Full Text] [Related]

  • 22. Effects of oral cisapride on small bowel motility in irritable bowel syndrome.
    Evans PR, Bak YT, Kellow JE.
    Aliment Pharmacol Ther; 1997 Oct; 11(5):837-44. PubMed ID: 9354190
    [Abstract] [Full Text] [Related]

  • 23. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K, Hazeena K, Thomas V, Kumar S, Jose T, Narayanan P.
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
    [Abstract] [Full Text] [Related]

  • 24. Role of colonic fermentation in the perception of colonic distention in irritable bowel syndrome and functional bloating.
    Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Tana P, Corazza GR.
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1242-7. PubMed ID: 16979386
    [Abstract] [Full Text] [Related]

  • 25. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A, Posserud I, Abrahamsson H, Simrén M.
    Aliment Pharmacol Ther; 2007 Sep 15; 26(6):953-61. PubMed ID: 17767480
    [Abstract] [Full Text] [Related]

  • 26. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
    Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC.
    Am J Gastroenterol; 2006 Jun 15; 101(6):1288-94. PubMed ID: 16771951
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome.
    Sadik R, Björnsson E, Simrén M.
    Eur J Gastroenterol Hepatol; 2010 Jan 15; 22(1):102-8. PubMed ID: 19701093
    [Abstract] [Full Text] [Related]

  • 29. Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.
    Azzaroli F, Mazzella G, Mazzeo C, Simoni P, Festi D, Colecchia A, Montagnani M, Martino C, Villanova N, Roda A, Roda E.
    Am J Gastroenterol; 1999 Sep 15; 94(9):2453-9. PubMed ID: 10484008
    [Abstract] [Full Text] [Related]

  • 30. [Small intestine motility and gastrointestinal hormone levels in irritable bowel syndrome].
    Zhao JH, Dong L, Hao XQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct 15; 27(10):1492-5. PubMed ID: 17959521
    [Abstract] [Full Text] [Related]

  • 31. Outcome of colectomy for slow-transit constipation in relation to presence of small-bowel dysmotility.
    Glia A, Akerlund JE, Lindberg G.
    Dis Colon Rectum; 2004 Jan 15; 47(1):96-102. PubMed ID: 14719156
    [Abstract] [Full Text] [Related]

  • 32. Abnormal colonic propagated activity in patients with slow transit constipation and constipation-predominant irritable bowel syndrome.
    Bassotti G, Chistolini F, Marinozzi G, Morelli A.
    Digestion; 2003 Jan 15; 68(4):178-83. PubMed ID: 14671425
    [Abstract] [Full Text] [Related]

  • 33. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome.
    Viramontes BE, Camilleri M, McKinzie S, Pardi DS, Burton D, Thomforde GM.
    Am J Gastroenterol; 2001 Sep 15; 96(9):2671-6. PubMed ID: 11569693
    [Abstract] [Full Text] [Related]

  • 34. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A, Chojnacki J, Wiśiewska-Jarosińska M, Stec-Michalska K, Szadkowski K, Smigielski J, Chojnacki C.
    Pol Merkur Lekarski; 2007 May 15; 22(131):366-8. PubMed ID: 17679369
    [Abstract] [Full Text] [Related]

  • 35. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L, Elia C, Navino M, Cisarò F, ARMONIA Study Group.
    Acta Biomed; 2007 Aug 15; 78(2):111-6. PubMed ID: 17933278
    [Abstract] [Full Text] [Related]

  • 36. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea.
    Chey WY, Jin HO, Lee MH, Sun SW, Lee KY.
    Am J Gastroenterol; 2001 May 15; 96(5):1499-506. PubMed ID: 11374689
    [Abstract] [Full Text] [Related]

  • 37. Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome.
    Kuiken SD, Lindeboom R, Tytgat GN, Boeckxstaens GE.
    Aliment Pharmacol Ther; 2005 Jul 15; 22(2):157-64. PubMed ID: 16011674
    [Abstract] [Full Text] [Related]

  • 38. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation.
    Abrahamsson H, Ostlund-Lindqvist AM, Nilsson R, Simrén M, Gillberg PG.
    Scand J Gastroenterol; 2008 Jul 15; 43(12):1483-8. PubMed ID: 18788050
    [Abstract] [Full Text] [Related]

  • 39. The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation.
    Chitkara DK, Bredenoord AJ, Cremonini F, Delgado-Aros S, Smoot RL, El-Youssef M, Freese D, Camilleri M.
    Am J Gastroenterol; 2004 Aug 15; 99(8):1579-84. PubMed ID: 15307880
    [Abstract] [Full Text] [Related]

  • 40. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
    Mearin F, Badía X, Balboa A, Benavent J, Caballero AM, Domínguez-Muñoz E, Garrigues V, Piqué JM, Roset M, Cucala M, Figueras M, RITMO Group.
    Aliment Pharmacol Ther; 2006 Mar 15; 23(6):815-26. PubMed ID: 16556184
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.